000			01591 a2200409 4500
005			20250515024832.0
264		0	_c20060724
008			200607s 0 0 eng d
022			_a1525-0016
024	7		_a10.1016/j.ymthe.2006.05.001 _2doi
040			_aNLM _beng _cNLM
100	1		_aWilliams, David A
245	0	0	_aGene therapy advances but struggles to interpret safety data in small animal models. _h[electronic resource]
260			_bMolecular therapy : the journal of the American Society of Gene Therapy _cJun 2006
300			_a1027-8 p. _bdigital
500			_aPublication Type: Editorial
650	0	4	_aAdenosine Deaminase _xdeficiency
650	0	4	_aAnimals
650	0	4	_aClinical Trials as Topic
650	0	4	_aDNA-Binding Proteins _xgenetics
650	0	4	_aDeficiency Diseases _xgenetics
650	0	4	_aDisease Models, Animal
650	0	4	_aGene Expression Regulation
650	0	4	_aGenetic Therapy _xmethods
650	0	4	_aGranulomatous Disease, Chronic _xgenetics
650	0	4	_aHumans
650	0	4	_aInterleukin Receptor Common gamma Subunit
650	0	4	_aMDS1 and EVI1 Complex Locus Protein
650	0	4	_aMice
650	0	4	_aNeoplasm Proteins _xgenetics
650	0	4	_aProto-Oncogenes
650	0	4	_aReceptors, Interleukin _xgenetics
650	0	4	_aSevere Combined Immunodeficiency _xgenetics
650	0	4	_aTranscription Factors _xgenetics
773	0		_tMolecular therapy : the journal of the American Society of Gene Therapy _gvol. 13 _gno. 6 _gp. 1027-8
856	4	0	_uhttps://doi.org/10.1016/j.ymthe.2006.05.001 _zAvailable from publisher's website
999			_c16285225 _d16285225